Astronomical R&D cost
& low success rate
ORGANOPlus StoryWe are an organochip innovation company leading human-centered drug development.
Who We Are
ORGANOPlus is a precision-biology company built around our flagship Multi-Organ Organoid Chip.
We provide ready-to-use, disease-specific models that let you evaluate small-molecule and microbiome-based therapeutics with rapid, human-relevant read-outs of efficacy, safety, and PK/PD. By translating complex human physiology into a single human-derived organoid chip, we radically shorten timelines and lower risk across the drug-discovery pipeline.
New‑modality therapies are
notoriously hard to evaluate
Poor translation of
animal data to humans
Animal‑ethics pressure& The spread of
alternative to animal testing legislation
The optimal evaluation solution accurately assessing novel modalities without animal testing and accelerating drug‑development efficiency
Our Mission
To make human biology the starting point for every therapy.
Through AI-driven precision analytics and our multi-organ, human-derived organoid chip platform, we replace animal models and unlock patient-relevant insights for new-modality therapeutics. By maximizing clinical success rates and compressing development timelines, we are pioneering a truly human-centric paradigm in drug discovery.
True Human Relevance
• Uses human-derived cells to recreate authentic human physiology
• Produces the human-relevant evidence
Organoid Chip
• Precision Human-Mimetic Organoid Chip Technology
• Disease- and organ-tailored chips that accommodate diversified MoA
AI PBPK Engine
• Physiologically based PK models fed by real-time chip data
• Optimizes clinical design, slashing early-stage attrition
Our Journey
